
Stryker Corporation SYK
Quarterly report 2026-Q1
added 05-11-2026
Country |
|
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NYSESPB |
Shares |
382 M |
Market Cap[1] |
$ 121 B |
EBITDA (LTM) |
$ 5.57 B |
P/E (LTM) |
34.34 |
P/S (LTM) |
4.51 |
EPS (LTM) |
8.23 |
Stryker Corporation is an international company specializing in the production of medical equipment and instruments for surgery. The company was founded in 1941 in the United States and has since become one of the leaders in its field.
Stryker Corporation offers a wide range of products, including implants for orthopedics, neurosurgery, traumatology, and other areas of medicine, as well as tools for surgical operations and rehabilitation equipment.
The company is actively developing and expanding its business around the world. Today, SYK has offices in more than 100 countries and holds leading positions in the medical equipment market.
One of the company's main goals is to create innovative products that will help improve the quality of life for patients and facilitate the work of medical professionals. Stryker Corporation also actively works on improving its technologies and processes to ensure high-quality products and maximum safety for patients.
Stryker Corporation is an example of a successful business that combines innovation, quality, and responsibility to patients.
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
IRIDEX Corporation
IRIX
|
$ 1.01 | - | $ 17.1 M | Nasdaq Global Select Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
ClearPoint Neuro
CLPT
|
$ 11.44 | -2.22 % | $ 324 M | Nasdaq Capital Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Alphatec Holdings
ATEC
|
$ 8.27 | 0.49 % | $ 1.24 B | Nasdaq Global Select Market | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
EDAP TMS S.A.
EDAP
|
$ 4.3 | -2.27 % | $ 161 M | Nasdaq Global Market | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
LivaNova PLC
LIVN
|
$ 73.83 | 0.26 % | $ 4.03 B | Nasdaq Global Select Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
LENSAR
LNSR
|
$ 6.09 | 2.35 % | $ 72.8 M | Nasdaq Capital Market | ||
|
Helius Medical Technologies
HSDT
|
$ 2.29 | -2.97 % | $ 50.5 M | Nasdaq Capital Market | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.46 | 0.17 % | $ 28.6 M | Nasdaq Capital Market | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 18.37 | -0.33 % | $ 431 M | Nasdaq Global Select Market,SPB | ||
|
Delcath Systems
DCTH
|
$ 11.02 | -3.76 % | $ 395 M | Nasdaq Capital Market | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
MiMedx Group
MDXG
|
$ 3.62 | 0.28 % | $ 535 M | Nasdaq Global Select Market | ||
|
Pulmonx Corporation
LUNG
|
$ 1.55 | 0.65 % | $ 63.1 M | Nasdaq Global Select Market | ||
|
Electromed
ELMD
|
$ 38.22 | -0.93 % | $ 323 M | NYSE American | ||
|
Myomo
MYO
|
$ 1.04 | 9.5 % | $ 43.5 M | NYSE American | ||
|
Butterfly Network
BFLY
|
$ 4.47 | -0.11 % | $ 1.1 B | NYSE | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
Sintx Technologies
SINT
|
$ 2.39 | 3.91 % | $ 6.63 M | Nasdaq Capital Market | ||
|
Orthofix Medical
OFIX
|
$ 10.75 | 3.27 % | $ 426 M | Nasdaq Global Select Market,SPB | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
Profound Medical Corp.
PROF
|
$ 6.83 | -2.01 % | $ 206 M | Nasdaq Global Select Market | ||
|
Globus Medical
GMED
|
$ 84.81 | 0.24 % | $ 11.5 B | NYSE,SPB | ||
|
Insulet Corporation
PODD
|
$ 154.87 | -1.29 % | $ 10.9 B | Nasdaq Global Select Market,SPB | ||
|
CONMED Corporation
CNMD
|
$ 37.23 | 0.57 % | $ 1.16 B | NYSE,SPB | ||
|
Inspire Medical Systems
INSP
|
$ 43.84 | -2.01 % | $ 1.29 B | NYSE,SPB | ||
|
Integer Holdings Corporation
ITGR
|
$ 89.28 | -0.8 % | $ 3.1 B | NYSE,SPB | ||
|
TransMedics Group
TMDX
|
$ 68.94 | 0.12 % | $ 2.34 B | Nasdaq Global Market | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | ||
|
Edwards Lifesciences Corporation
EW
|
$ 85.78 | 3.1 % | $ 50.2 B | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.